| Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study S Dubois, PJ Viailly, S Mareschal, E Bohers, P Bertrand, P Ruminy, ... Clinical cancer research 22 (12), 2919-2928, 2016 | 156 | 2016 |
| Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas D Vallois, MPD Dobay, RD Morin, F Lemonnier, E Missiaglia, M Juilland, ... Blood 128 (11), 1490-1502, 2016 | 151 | 2016 |
| Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology K Belarbi, S Burnouf, FJ Fernandez-Gomez, C Laurent, S Lestavel, ... Neurobiology of disease 43 (2), 486-494, 2011 | 149 | 2011 |
| Comprehensive mutational profiling of core binding factor acute myeloid leukemia N Duployez, A Marceau-Renaut, N Boissel, A Petit, M Bucci, S Geffroy, ... Blood, The Journal of the American Society of Hematology 127 (20), 2451-2459, 2016 | 148 | 2016 |
| Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells AF Dessein, L Stechly, N Jonckheere, P Dumont, D Monté, E Leteurtre, ... Cancer research 70 (11), 4644-4654, 2010 | 112 | 2010 |
| Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations JB Micol, N Duployez, N Boissel, A Petit, S Geffroy, O Nibourel, ... Blood, The Journal of the American Society of Hematology 124 (9), 1445-1449, 2014 | 106 | 2014 |
| Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations JB Micol, N Duployez, N Boissel, A Petit, S Geffroy, O Nibourel, ... Blood, The Journal of the American Society of Hematology 124 (9), 1445-1449, 2014 | 106 | 2014 |
| Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations JB Micol, N Duployez, N Boissel, A Petit, S Geffroy, O Nibourel, ... Blood, The Journal of the American Society of Hematology 124 (9), 1445-1449, 2014 | 106 | 2014 |
| IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association H Debarri, D Lebon, C Roumier, M Cheok, A Marceau-Renaut, O Nibourel, ... Oncotarget 6 (39), 42345, 2015 | 81 | 2015 |
| Genomic landscape of CXCR4 mutations in Waldenström macroglobulinemia S Poulain, C Roumier, A Venet-Caillault, M Figeac, C Herbaux, G Marot, ... Clinical Cancer Research 22 (6), 1480-1488, 2016 | 69 | 2016 |
| Accurate Classification of Germinal Center B-Cell–Like/Activated B-Cell–Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase–Multiplex Ligation … S Mareschal, P Ruminy, C Bagacean, V Marchand, M Cornic, JP Jais, ... The Journal of Molecular Diagnostics 17 (3), 273-283, 2015 | 60 | 2015 |
| Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+ CD56+ haematodermic neoplasms and contribute … F Jardin, M Callanan, D Penther, P Ruminy, X Troussard, JP Kerckaert, ... Leukemia 23 (4), 698-707, 2009 | 57 | 2009 |
| Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P–mutated diffuse large B-cell lymphoma: analysis of 361 cases S Dubois, PJ Viailly, E Bohers, P Bertrand, P Ruminy, V Marchand, ... Clinical Cancer Research 23 (9), 2232-2244, 2017 | 55 | 2017 |
| Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma F Jardin, A Pujals, L Pelletier, E Bohers, V Camus, S Mareschal, S Dubois, ... American journal of hematology 91 (9), 923-930, 2016 | 55 | 2016 |
| Fast multiclonal clusterization of V (D) J recombinations from high-throughput sequencing M Giraud, M Salson, M Duez, C Villenet, S Quief, A Caillault, N Grardel, ... BMC genomics 15 (1), 1-12, 2014 | 54 | 2014 |
| Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease E Mutez, A Nkiliza, K Belarbi, A de Broucker, C Vanbesien-Mailliot, ... Neurobiology of disease 63, 165-170, 2014 | 48 | 2014 |
| Sorting by reversals with common intervals M Figeac, JS Varré Algorithms in Bioinformatics, 26-37, 2004 | 46 | 2004 |
| MicroRNAs in lymphoma, from diagnosis to targeted therapy F Jardin, M Figeac Current Opinion in Oncology 25 (5), 480-486, 2013 | 42 | 2013 |
| Neurofibromatosis‐1 gene deletions and mutations in de novo adult acute myeloid leukemia E Boudry‐Labis, C Roche‐Lestienne, O Nibourel, N Boissel, C Terre, ... American journal of hematology 88 (4), 306-311, 2013 | 42 | 2013 |
| Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia. JE Bibault, M Figeac, N Hélevaut, C Rodriguez, S Quief, S Sebda, ... Oncotarget 6 (26), 22812-22821, 2015 | 40 | 2015 |
